NewslettersCell Therapy NewsUncategorizedCD38 Knockout Natural Killer Cells Expressing an Affinity Optimized CD38 Chimeric Antigen Receptor Successfully Target Acute Myeloid Leukemia with Reduced Effector Cell FratricideBy Justin.choi - February 2, 2022013Researchers developed a CD38 CAR-NK cell therapy for acute myeloid leukemia, first by using an NK cell line which had low baseline CD38 expression and subsequently NK cells expanded from healthy donors.[Haematologica] 6445212 BBBBBBBB items 1 apa 0 default asc 1 171391 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article